These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29934919)

  • 21. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.
    Schwimmer JB; Middleton MS; Behling C; Newton KP; Awai HI; Paiz MN; Lam J; Hooker JC; Hamilton G; Fontanesi J; Sirlin CB
    Hepatology; 2015 Jun; 61(6):1887-95. PubMed ID: 25529941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
    Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
    Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
    Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R
    Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
    Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
    Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
    Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
    Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
    Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
    Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
    Marti-Aguado D; Ten-Esteve A; Baracaldo-Silva CM; Crespo A; Coello E; Merino-Murgui V; Fernandez-Paton M; Alfaro-Cervello C; Sánchez-Martín A; Bauza M; Jimenez-Pastor A; Perez-Girbes A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Latorre M; Monton C; Escudero-García D; Bosch-Roig I; Alberich-Bayarri Á; Marti-Bonmati L
    Front Endocrinol (Lausanne); 2023; 14():1213441. PubMed ID: 37600695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease].
    Wang L; Qu HJ; Yang WJ; Ding JP; Shi JP; Zhang QL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1204-1208. PubMed ID: 38238955
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
    Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
    J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
    Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
    Gu J; Liu S; Du S; Zhang Q; Xiao J; Dong Q; Xin Y
    Eur Radiol; 2019 Jul; 29(7):3564-3573. PubMed ID: 30899974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
    Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Kühn JP; Meffert P; Heske C; Kromrey ML; Schmidt CO; Mensel B; Völzke H; Lerch MM; Hernando D; Mayerle J; Reeder SB
    Radiology; 2017 Sep; 284(3):706-716. PubMed ID: 28481195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.